Interestingly, GSDME, in turn, enable us to enhance the intrinsic apoptotic pathway in cancer cells by forming pores in the mitochondria with GSDME-N and liberating proapoptotic factors (including Cyt c and HtrA2) [24]. The gene discussed is HTRA2; the disease is cancer.